In an important milestone towards market introduction, Median Technologies announces that its CADe/CADx Software as Medical Device (SaMD), eyonis™ LCS, has demonstrated excellent performance in an ...
SOPHIA ANTIPOLIS, France - Median Technologies has announced a significant advancement in its lung cancer screening technology, eyonis™ LCS, following an independent verification study. The software, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback